New York Hedge Fund Seeks Sale Of Microchip Company

Mar 24 2008 | 10:59am ET

Obrem Capital Management thinks a circuit has burned out at microchip manufacturer Micrel. And it has the solution: Sell.

The New York hedge fund earlier this month sent a letter to Micrel management, chastising it for “a poorly-developed outsourcing strategy” and “bloated cost structure.” The firm, which owns 9.6% of San Jose, Calif.-based Micrel, has asked to meet with the company’s board of directors, but it has already reached its conclusion: “the Board would maximize value for Micrel’s shareholders by selling the company to a strategic buyer,” namely a larger semiconductor company.

According to Obrem—which demands at a minimum that the company set up a special committee to investigate strategic alternatives—current management will be unable to boost sales or improve Micrel’s cost structure.


In Depth

U.S. Treasury Moves on Reinsurance Loophole

Apr 24 2015 | 5:11pm ET

The U.S. Treasury Department has released proposed rules aimed at limiting the ability...

Lifestyle

Puerto Rico Woos The Rich But So Far Gains Little

Apr 17 2015 | 2:45am ET

Hedge fund manager Rob Rill grins. He has just had word that U.S. financial regulators...

Guest Contributor

Opportunities Ahead: Asian Fixed Income and Currency Markets

Apr 24 2015 | 6:18am ET

For hedge funds focusing on Asia, the policy uncertainty, unclear interest rate...

 

Editor's Note